Abstract: The present invention includes a concentration of at least 7.5% w/w saccharide other than trehalose, a preservative, in a buffered solution, wherein the composition is formulated for optic or otic administration. In certain embodiments, the composition is used to treat dry eyes, presbyopia, eye pain, blurred vision, confused mental function, scotoma, allergies, reduced craving for sugar, blocked tear ducts, tremors, vision and cognitive changes due to concussion, vertigo, TBI, loss of cognitive function as a result of traumatic brain injury, multiple sclerosis, Parkinson's disease, Alzheimer's disease, attention deficit disorder, attention deficit hyperactivity disorder, or Guillain-Barre syndrome.

Abstract: A monocular apparatus and method is disclosed for selectively stimulating cortical brain activity of a patient with hemispheric brain differences using light and/or sound includes exposing a patient to one or more lights (12) placed in close proximity to a patient's eyes (20, 30) wherein the one or more of lights (12) selectively stimulate the non-dominant eye (30) connected to the non-dominant cerebral hemisphere. The present invention may be of particular use for a patient diagnosed with brain injury and/or a brain dysfunction, such as cognitive, seizure, mood, panic, dissociative, or learning disorder.

Abstract: An apparatus and method is disclosed for selectively stimulating cortical brain activity of a patient with hemispheric brain differences using light and/or sound includes exposing the patient to one or more lights (12) placed in close proximity to a patient's eyes (20, 30) wherein the one or more of lights (12) selectively stimulate the non-dominant eye (30) connected to the non-dominant cerebral hemisphere.